CCA
TDOC icon

Criterion Capital Advisors’s Teladoc Health TDOC Stock Holding History

Criterion Capital Advisors’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$1.62K Hold
166
– – ﹤0.01% 330
2024
Q3 		$1.62K Hold
166
– – ﹤0.01% 330
2024
Q2 		$1.62K Hold
166
– – ﹤0.01% 330
2024
Q1 		$2.51K Hold
166
– – ﹤0.01% 317
2023
Q4 		$3.58K Buy
+166
New +$3.06K ﹤0.01% 306

Other funds holding TDOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Criterion Capital Advisors's TDOC Position: Q4 2024 in Review

Criterion Capital Advisors held its Teladoc Health (TDOC) position steady in Q4 2024 at 166 shares worth $1.62K. The position accounts for ﹤0.01% of the portfolio, ranked #330.

Criterion Capital Advisors first reported a position in TDOC in Q4 2023 and has held it in 5 quarters since. The position peaked at $3.58K in Q4 2023. 380 funds tracked by Wall St. Rank hold TDOC as of Q4 2024.

  • Criterion Capital Advisors held 166 shares of Teladoc Health worth $1.62K as of Q4 2024.
  • Criterion Capital Advisors left its Teladoc Health share count unchanged in Q4 2024.
  • Teladoc Health made up ﹤0.01% of Criterion Capital Advisors's portfolio in Q4 2024, its #330 holding.
  • Criterion Capital Advisors first reported a position in Teladoc Health in Q4 2023 and has held it in 5 quarters since.
  • Criterion Capital Advisors's Teladoc Health position peaked at $3.58K in Q4 2023.
  • 380 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2024.

Based on Criterion Capital Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.